阿司匹林服用与头颈癌:INHANCE联盟内的汇总分析
在INHANCE联盟的4项病例对照研究(2024例病例、4196例对照)中,阿司匹林服用与头颈癌总体风险呈负相关(OR=0.48;95%CI:0.26,0.91),喉癌结果相似(OR=0.54;95%CI:0.30,0.96)。服用时长的分析证实了头颈癌总体结果,并显示口咽癌和喉癌 also 呈负相关。
要点
- 阿司匹林服用与头颈癌总体风险降低相关(OR=0.48;95%CI:0.26,0.91)。
- 喉癌风险 similarly 降低(OR=0.54;95%CI:0.30,0.96)。
- 服用时长分析显示口咽癌和喉癌 also 呈负相关。
核心结论
- 本研究提示阿司匹林服用可能降低头颈癌风险,主要由喉癌和口咽癌风险降低驱动。
研究设计与样本
- INHANCE联盟内4项病例对照研究,共2024例病例和4196例对照。
- 采用逻辑回归估计各研究的OR和95%CI,并用DerSimonian-Laird随机效应模型汇总。
- 服用时长与头颈癌关系的非线性用分数多项式建模。
主要发现
- 阿司匹林与头颈癌总体呈负相关(OR=0.48;95%CI:0.26,0.91)。
- 喉癌结果相似(OR=0.54;95%CI:0.30,0.96)。
- 服用时长分析证实头颈癌总体结果,并显示口咽癌和喉癌 also 呈负相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aspirin intake might be inversely associated with head and neck cancer (HNC). Thus, we investigated this relationship within the International Head and Neck Cancer Epidemiology (INHANCE) consortium. METHODS: Four case-control studies within the INHANCE consortium were included (2024 cases, 4196 controls). Study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression and subsequently pooled with DerSimonian-Laird random-effects model. Nonlinearity of the relationship between duration of intake and HNC was modeled with fractional polynomials. RESULTS: Aspirin was inversely associated with HNC overall (OR = 0.48; 95% CI: 0.26, 0.91). Results for laryngeal cancer were similar (OR = 0.54; 95% CI: 0.30, 0.96). Analysis on duration of intake confirmed findings for HNC overall, showing also inverse associations for oropharyngeal and laryngeal cancer. CONCLUSIONS: This study suggests that aspirin intake may reduce the risk of HNC, driven mainly by decreases in risk for laryngeal and oropharyngeal cancer.
引用
- Sassano M, Taborelli M, Boccia S, et al. Aspirin intake and head and neck cancer: A pooled analysis within the INHANCE consortium. Head Neck. 2024. PMID: 38229229. doi:10.1002/hed.27638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。